Community Health Worker Program for Cardiovascular Disease
(H2H Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What data supports the effectiveness of the treatment Heart to Heart in the Community Health Worker Program for Cardiovascular Disease?
Research shows that community health workers can effectively help reduce the risk of heart disease by identifying and managing risk factors like high blood pressure and unhealthy lifestyle habits. Programs using community health workers have been successful in improving heart health in various communities, suggesting that the Heart to Heart treatment could be effective in similar ways.12345
Is the Community Health Worker Program for Cardiovascular Disease safe for humans?
Research shows that Community Health Workers (CHWs) are effective in improving care for chronic diseases like heart disease and high blood pressure, and they help people access and stick to their treatments. There is no specific mention of safety issues, suggesting that the program is generally considered safe for humans.13678
How does the Community Health Worker Program for Cardiovascular Disease differ from other treatments?
This treatment is unique because it uses community health workers (CHWs) to prevent and manage cardiovascular disease, especially in underserved populations. Unlike traditional medical treatments, this approach focuses on community-based interventions and education to reduce risk factors and improve health outcomes.126910
What is the purpose of this trial?
This study is being done to evaluate whether a program called Heart to Heart, that helps patients make a more informed decision about cardiac rehab (CR), is interesting, acceptable to participants, and whether participants would recommend it to others.
Research Team
Lena Matthews, MD
Principal Investigator
Johns Hopkins University
Eligibility Criteria
This trial is for individuals with cardiovascular disease who are considering cardiac rehabilitation (CR). The study aims to help patients make informed decisions about CR and assess the program's appeal and recommendation potential.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete a baseline survey and medical record abstraction is conducted
Intervention
Participants receive the H2H intervention with 4 to 8 coaching sessions over 3 months
Follow-up
Participants are monitored for changes in health-related quality of life, depressive symptoms, perceived stress, and physical activity
Long-term Follow-up
Participants are monitored for all-cause hospitalization and mortality
Treatment Details
Interventions
- Heart to Heart
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator